India’s pet care industry has crossed an estimated $3.6 billion in 2024 and projected to hit $10 – $24 billion by 2032 due to rising pet ownership, greater focus on preventive healthcare and the increasing adoption of long-term nutrition. While food, grooming and accessories account for a major share of the sector, the fastest expansion is happening in pet health supplements, a category where structured, species-specific formulations remain limited.
Startups like Supertails, Wiggles, Heads Up For Tails, Drools and newer startups have helped build awareness, but most offerings still rely on generic blends rather than scientifically designed solutions tailored individually for dogs, cats and horses.
This is the gap where Venttura Bioceuticals has positioned itself as a health-focused brand building condition-specific, premium quality, pharma-standard supplements designed for the biological needs of each species.
The Founding Journey: From Observations to a Focused Brand
Many chronic pet health issues continued to persist despite improved veterinary care, primarily because both pet parents and vets lacked reliable, species-specific nutritional solutions. Amid these gaps, founders Rajas Kulkarni and Uday Kulkarni felt there was room for a more structured, research-informed supplement ecosystem.
Founded in 2013, Venttura Bioceuticals began with extensive discussions with vets, breeders and pet parents across metro and semi-urban markets. The founders’ early objective was to build a company centered on preventive and supportive nutrition, supported by regulated manufacturing, controlled ingredient sourcing and thorough documentation, areas that were inconsistent across the pet wellness segment.
“We understood early that supplements cannot be treated like treats nor should they be considered medicines,” the founders shared during their internal discussions. “They need the same discipline and testing standards expected in human nutrition.”
A Clearly Defined Product Philosophy
Venttura operates through a manufacturing and quality framework rooted in pharma standards. All its products are made in GMP and ISO-certified plants, using pharma and human-grade ingredients backed with COAs from reputed vendors.
According to the company, every batch is recorded, and control samples are retained for quality verification. Each formula undergoes third-party lab testing for contaminants, microbial load and ingredient accuracy.
As the founders explain, their products do not fall under the purview of FSSAI because the compositions are designed as specialised supportive veterinary formulations rather than food-based products.
The company’s offerings span three distinct species-specific ranges, each designed around biological and metabolic needs.
Petraceuticals for Dogs
This is Venttura’s largest and most comprehensive range, covering areas such as skin and coat health, joint and mobility support, detoxification, anaemia management, general wellness, immunity and multi-nutrient blends. The company states that this remains its core revenue driver, having grown 6x in recent years.
Cat-Specific Range
Venttura Bioceuticals is among the first Indian brands to build an entirely cat-focused supplement line. This includes products for liver and bladder health, skin and coat improvement, immune support and overall wellness, formulations crafted specifically for feline metabolism.
Equiceuticals for Horses
This range includes all-in-one growth and performance formulations, stamina and recovery blends, hoof and joint support, liver and digestive aid, lactation support for mares and omega-rich products. The segment targets performance-led and long-term equine wellness needs.
Across all categories, Venttura Bioceuticals maintains a focus on condition-led, species-specific nutrition rather than broad-spectrum blends.
Where Venttura Stands Today: Numbers & Growth
The company reports that it has served over 1 million pet parents so far, with an internal target of reaching 5 million in the coming years. Over the last two years, Venttura states that it has seen an overall sales growth of 6–7x across channels.
Online Business
Venttura sells through its own website and marketplaces including Amazon, Flipkart, Snapdeal and Supertails. As per the company’s internal data, online sales have been growing at nearly 30% month-on-month. The brand also notes a 4x jump in volumes for its best-performing SKUs and a steady rise in repeat purchases across platforms.
Offline Business
Historically, Venttura operated primarily as a B2B brand and continues to expand across veterinary clinics, pet stores, chemists and breeders. The company avoids supermarket and grocery retail to maintain product category discipline.
The startup claims their offline sales have grown by 102%, largely driven by veterinary recommendations and stronger distributor networks.
This year, Venttura prioritised deeper penetration in existing regions instead of geographic expansion. The focus remained on strengthening veterinary relationships and expanding digital presence for direct consumer engagement.
The company shares that it has raised funding exclusively through private equity and is now looking to secure additional capital in the near future to scale its operations, broaden its product categories and expand into global markets across Asia, Europe and the US.
Venttura’s Position in a Competitive Market
As larger players increase their presence in supplements, Venttura differentiates itself through its species-specific approach, its holistic formulations using novel ingredients, pharma-style manufacturing discipline, long-term condition-based solutions and a hybrid B2B + D2C model. According to the founders they don’t compete on just having products; they compete on science, quality and getting visible results with their supplements.
The founders note that preventive nutrition is steadily gaining acceptance, with more pet parents shifting from reactive, emergency-based purchasing to long-term supplementation guided by vets.
The Road Ahead
India’s pet population is projected to cross 31 million by 2025, with supplements expected to form one of the fastest-growing segments. As awareness around condition-based, long-term nutrition increases, structured and science-backed brands are likely to shape market evolution.
Venttura’s roadmap includes expanded digital D2C channels, expanding their product portfolios and driving deeper community interaction. Venttura Bioceuticals will soon be launching a first of its kind dog food in the market after having completed a series of market trials.
The founders, Rajas and Uday believe that long-term impact will depend on educating pet parents, building responsible supplementation habits and maintaining strong collaboration with veterinary professionals and all stakeholders in the pet care industry.
